Agonists By Bright Minds, A Biotechnology Company, Opens New Gateways To Healing The Mind

The year 2021 marked the beginning of psychedelic researches in public, as many biotechnology companies emerged as active players in this industry. Research organizations, such as Bright Minds Biosciences, a biotechnology company, raised above $2000 million for their research projects. The use of psychedelics has been tabooed since 1960 because the US included almost every psychoactive drug as a schedule I drug and put a ban on its use.